New Jersey bills · 2026-2027 Regular Session
New Jersey S 4194
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
- Vitale, Joseph F. (Democratic)
- Gopal, Vin (Democratic)
- Mukherji, Raj (Democratic)
Summary
No official summary is available for this bill.
Latest action(Jun 30, 2026): Substituted by A4852 (ACS)
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jun 30, 2026 · House
Substituted by A4852 (ACS) - Jun 11, 2026 · Senate
Reported from Senate Committee as a Substitute, 2nd Reading - May 11, 2026 · Senate
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee